Pinsent Masons advises 4D Pharma PLC on innovative move to NASDAQ
28 Oct 2020 | 10:31 am | 1 min. read
Multinational law firm Pinsent Masons has advised AIM listed biotech company 4D Pharma plc (4D) on its acquisition of Longevity Acquisition Corporation, a special-purpose acquisition company (SPAC) listed on NASDAQ. Upon completion of the transaction 4D will apply for its American Depositary Shares to be admitted to trading on NASDAQ.
4D, who are leading the development of live biotherapeutic products, are believed to be the first UK biotech to make the move to NASDAQ via the acquisition of a SPAC, breaking new ground for UK listed biotechs. The Company will also maintain its current listing on AIM.
With 4D acquiring the SPAC in order to inherit its listing on NASDAQ, they are able to by-pass the usual nine month lead-in time foreign issuers have to contend with when seeking a direct listing on NASDAQ.
The Pinsent Masons team was led by Charles Waddell and Sunjay Malhotra with assistance from Julian Stanier, Amy Moore and Nathalie Goetsches; US securities advice was provided by Roberta Markovina and Beatrice Kelly; Eloise Walker, Jamie Robson and Daniel Place assisted on UK tax matters; and Fleur Benns and James Sullivan-Tailyour provided assistance with regards to 4D’s share option plans.
Commenting on the transaction, lead partner at Pinsent Masons Charles Waddell said:
"We have enjoyed working with 4D for a number of years, they are at the cutting edge of live biotherapeutic products and this transaction is an important step in their future development and access to key to international markets.
Given the number of European biotechs that covet a move to NASDAQ, and notwithstanding the complex financing structures of SPACs, this deal highlights that there is an alternative route to the US markets. It is therefore unlikely to be the last biotech we see looking at SPACs to access the deep pool of sophisticated investors in the US."
Key Contacts
Latest press releases
Show me all press releasesPinsent Masons advised La Banque Postale and Bpifrance
Multinational law firm Pinsent Masons in Paris advised La Banque Postale and Bpifrance in connection with the financing of the repowering of two wind farms (Marsanne and Grand Bois) owned by funds managed by Octopus Energy Generation, for an amount exceeding €83 million.
Pinsent Masons advises INDY Cinema on its acquisition by VERSANT
Multinational law firm Pinsent Masons has advised international cinema technology business INDY Cinema (INDY) on its acquisition by New York-based VERSANT, an industry-changing media and entertainment company.
Pinsent Masons and Central Saint Martins unveil new exhibition celebrating emerging artists
Multinational law firm Pinsent Masons, in collaboration with the world-renowned art and design college Central Saint Martins (CSM), University of the Arts London has announced the winner of its inaugural Prize celebrating emerging creative talent at an exhibition at its London headquarters, Crown Place.
People who viewed this press release also viewed
Show me all press releasesPinsent Masons advises INDY Cinema on its acquisition by VERSANT
Multinational law firm Pinsent Masons has advised international cinema technology business INDY Cinema (INDY) on its acquisition by New York-based VERSANT, an industry-changing media and entertainment company.
Pinsent Masons advises on acquisition of Alba Renewables
Multinational law firm Pinsent Masons has advised Southeast Asia-based clean energy developer Alba Renewables on its acquisition by a leading global investment firm.
Pinsent Masons advises Great British Energy, National Wealth Fund and Scottish National Investment Bank on Pentland Investment
Multinational law firm Pinsent Masons has advised Great British Energy (“GBE”), the National Wealth Fund (“NWF”) and the Scottish National Investment Bank (“SNIB”) on their acquisition of a stake in Pentland Offshore Wind Farm from Copenhagen Infrastructure Partners (“CIP”) and agreed to provide an aggregate investment of up to £150,000,000 in the project.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on
Location contacts
Europe: [email protected]
Asia: [email protected]
Middle East: [email protected]
Australia: [email protected]